Inventor · disambiguated record
Chun-Su Yuan
Also filed as: YUAN CHUN-SU
8 granted patents·18 pending applications·501 citations·filing 1997–2019
88Inventor score
Top patents by PatentIndex Score
26 records- 0196US6608075B2Use of methylnaltrexone and related compoundsUNIV CHICAGO·Filed 2001·Granted Aug 19, 2003·88 cites·38 claims
- 0295US5972954AUse of methylnaltrexone and related compoundsARCH DEV CORP·Filed 1997·Granted Oct 26, 1999·222 cites·46 claims
- 0393US6559158B1Use of methylnaltrexone and related compounds to treat chronic opioid use side affectsUR LABS INC·Filed 2000·Granted May 6, 2003·79 cites·43 claims
- 0493US6274591B1Use of methylnaltrexone and related compoundsFiled 1998·Granted Aug 14, 2001·110 cites·30 claims
- 0575US2009312359A1Use of methylnaltrexone and related compounds for treatment of gastrointestinal dysfunction induced by endogenous opioidsFOSS JOSEPH F·Filed 2008·Application pending·0 cites
- 0674US8524731B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationMOSS JONATHAN·Filed 2006·Granted Sep 3, 2013·2 cites·10 claims
- 0767US9662325B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2014·Granted May 30, 2017·0 cites·9 claims
- 0867US2010087472A1Use of methylnaltrexone and related compound to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2009·Application pending·0 cites
- 0964US2004167148A1Oral use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFiled 2004·Application pending·0 cites
- 1064US2004162306A1Use of methylnal trexone and related compounds to treat constipation in chronic opioid usersFiled 2004·Application pending·0 cites
- 1163US2011250278A1Particles containing an opioid receptor antagonist and methods of useUNIV CHICAGO·Filed 2009·Application pending·0 cites
- 1260US10507188B2Particles containing an opioid receptor antagonist and methods of useUNIV CHICAGO·Filed 2017·Granted Dec 17, 2019·0 cites·9 claims
- 1360US2003158220A1Use of methylnaltrexone and related compounds to treat chronic opioid use side effectsFiled 2003·Application pending·0 cites
- 1460US2003065003A1Use of methylnaltrexone and related compoundsUNIV CHICAGO·Filed 2002·Application pending·0 cites
- 1559US2012277260A1Use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2012·Application pending·0 cites
- 1658US2012190702A1Use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2011·Application pending·0 cites
- 1758US2005048117A1Use of methylnaltrexone and related compoundsFiled 2004·Application pending·0 cites
- 1858US2020101026A1Particles containing an opioid receptor antagonist and methods of useUNIV CHICAGO·Filed 2019·Application pending·0 cites
- 1957US2004162307A1Use of methylnaltrexone and related compounds to induce laxation in chronic opioid usersFiled 2004·Application pending·0 cites
- 2057US2004167147A1Oral use of methylnaltrexone and related compounds to induce laxation in chronic opioid usersFiled 2004·Application pending·0 cites
- 2155US9675602B2Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2013·Granted Jun 13, 2017·0 cites·10 claims
- 2255US2003187010A1Use of methylnaltrexone and related compounds to treat chronic opioid use side effectsFiled 2003·Application pending·0 cites
- 2354US2017252336A1Use of opioid antagonists to attenuate endothelial cell proliferation and migrationUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 2440US2003022909A1Use of methylnaltrexone to treat immune suppressionUNIV CHICAGO·Filed 2002·Application pending·0 cites
- 2538US2002136785A1Ginseng berry extracts and pharmaceutical compositions from ginseng berry for the treatment of type 2 diabetes and obesityFiled 2001·Application pending·0 cites
- 2637US2015190523A1Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulationUNIV CHICAGO·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →